Human medicines European public assessment report (EPAR): Synagis, palivizumab, Date of authorisation: 13/08/1999, Revision: 46, Status: Authorised
Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Imaavy, nipocalimab, Date of authorisation: 28/11/2025, Status: Authorised
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 December 2025
New medicine to treat non-muscle invasive bladder cancer
Summary of opinion: Recarbrio, 11/12/2025 Positive
Summary of opinion: Simponi, 11/12/2025 Positive
Summary of opinion: Vfend, 11/12/2025 Positive
Summary of opinion: Winrevair, 11/12/2025 Positive
Summary of opinion: Dovprela (previously Pretomanid FGK), 11/12/2025 Positive